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ABSTRACT 
Genetically-encoded Förster’s Resonance Energy Transfer (FRET) biosensors are indispensable tools to sense 
the spatiotemporal dynamics of signal transduction pathways. Investigating the crosstalk between different 
signalling pathways is becoming increasingly important to follow cell development and fate programs. To this 
end, FRET biosensors must be optimised to monitor multiple biochemical activities simultaneously and in single 
cells. In addition, their sensitivity must be increased to follow their activation even when the abundance of the 
biosensor is low. 
We describe here the development of a second generation of Aurora kinase A/AURKA biosensors. First, we 
adapt the original AURKA biosensor –GFP-AURKA-mCherry– to multiplex FRET by using dark acceptors as 
ShadowG or ShadowY. Then, we use the novel superYFP acceptor protein to measure FRET by 2-colour 
Fluorescence Cross-Correlation Spectroscopy, in cytosolic regions where the abundance of AURKA is 
extremely low and undetectable with the original AURKA biosensor. 
These results pave the way to the use of FRET biosensors to follow AURKA activation in conjunction with 
substrate-based activity biosensors. In addition, they open up the possibility of tracking the activation of small 
pools of AURKA and its interaction with novel substrates, which would otherwise remain undetectable with 
classical biochemical approaches. 
 
 
Keywords: Aurora kinase A/AURKA, mitosis, fluorescence anisotropy, multiplex FRET, superYFP, 2-color 
FCCS. 
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Genetically-encoded Förster’s Resonance Energy Transfer (FRET) biosensors have revolutionised our 
knowledge of signal transduction pathways in the cell. The capability of sensing the activation of kinases, the 
activity of caspases, or the transport of second messengers as Ca2+ or cAMP opened up the possibility of 
following biochemical reactions in real time and with a spatiotemporal resolution 1–3. The novel frontier of these 
probes consists in combining two or more FRET biosensors at a time to unravel the interdependence of signal 
transduction pathways, an approach known as multiplex FRET 4–10.  
AURKA is a serine/threonine kinase with multiple functions in the cell. AURKA was first described to be a mitotic 
protein with multiple partners and playing key roles in centrosome maturation, in the regulation of mitotic timing, 
and in building and stabilising the mitotic spindle 11. Nonetheless, it is now becoming increasingly clear that 
AURKA has several roles outside of mitosis, such as favouring neurite outgrowth 12, transcriptional activity 
through the MYC promoter 13, and mitochondrial homeostasis 14,15. In this light, it is still unknown whether mitotic 
and non-mitotic functions of AURKA are made possible by a single, recycling pool of the kinase or by different 
pools at specific subcellular locations. Given the fact that the abundance of AURKA is regulated throughout the 
cell cycle, sensitive techniques are required to decipher the role of AURKA at selected compartments and 
especially when the abundance of the protein is low as in G1 phase. 
 We previously engineered an AURKA FRET biosensor where the donor-acceptor FRET pair flanks the 
entire AURKA sequence. This new strategy for FRET biosensors allowed us to replace the endogenous kinase 
in mammalian cells, and to report on its activation at centrosomes both at mitosis and during G1 phase 16. We 
here develop two independent strategies to ameliorate this probe: first, a single-colour AURKA biosensor for 
multiplex FRET and second, a method to estimate FRET efficiency in regions where the abundance of AURKA 
is low. We show that FRET donor-acceptor pairs with dark acceptors are preferable for engineering multiplex 
FRET approaches with the AURKA biosensor, rather than fluorescence anisotropy. We also optimise 2-colour 
Fluorescence Correlation Spectroscopy (2c-FCCS), together with an improved donor-acceptor FRET pair, to 
detect AURKA activation in cytoplasmic regions with low AURKA abundance.  
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MATERIAL AND METHODS 
Expression vectors and molecular cloning procedures 
The GFP-AURKA, GFP-AURKA-mCherry and the GFP-AURKA Lys162Met-mCherry vectors suitable for 
expression in mammalian cells were previously described 16. To obtain GFP-AURKA-GFP, GFP-AURKA under 
the AURKA minimal promoter sequence (CTTCCGG) was subcloned into a pCDNA6 vector (Thermo Fisher 
Scientific) into the Eam1105I/NheI restriction sites, and a second EGFP was inserted into the NheI/NotI sites. 
The GFP monomer and tandem dimer were previously described 17. A plasmid containing the mTurquoise2 was 
obtained from Dorus Gadella, together with the plasmids encoding ShadowG and ShadowY, which were 
obtained from Hideji Murakoshi. These plasmids were obtained via Addgene and have been previously 
described 18–20. To obtain AURKA-mTurquoise2, AURKA was subcloned into a pEGFP-N1 vector into the 
NotI/BamHI cloning site, while EGFP was replaced by mTurquoise2. To obtain ShadowG-AURKA-mTurquoise2, 
ShadowY-AURKA-mTurquoise2 and superYFP-AURKA-mTurquoise2, ShadowG, ShadowY or superYFP were 
inserted into the XhoI/HindIII restriction sites of AURKA-mTurquoise2, respectively. To obtain the mTurquoise2-
ShadowG tandem, a tandem containing mTFP1 and ShadowG 9 was digested with BglII/AgeI to replace mTFP1 
with mTurquoise2. To obtain the mTurquoise2-ShadowY tandem, a pEGFP-N1 backbone vector containing 
mTurquoise2 was digested with BglII/BamHI to insert ShadowY. To create the mTurquoise2-superYFP tandem, 
a pEGFP-N1 backbone vector containing a tandem of Aquamarine and superYFP was digested with AgeI/BglII 
to replace Aquamarine with mTurquoise2. To obtain a vector mTurquoise2 alone, the mTurquoise2-superYFP 
tandem was digested with BamHI to eliminate the superYFP fluorophore. Cloning reactions were performed with 
the NEBuilder HiFi DNA Assembly Mix (New England Biolabs) or by T4 DNA ligase (Thermo Fisher Scientific). 
All cloning reactions were verified on a 3130 XL sequencer (Applied Biosystems). All restriction enzymes were 
purchased from Thermo Fisher Scientific. The Lys162Met variant for all AURKA biosensors analysed in the 
study were obtained from the corresponding wild-type constructs by QuikChange site-directed mutagenesis 
(Stratagene) with the following primers: 5’-CAAGTTTATTCTGGCTCTTATGGTGTTATTTAAAGCTCAGCT-3’ 
(sense) and 5’-AGCTGAGCTTTAAATAACACCATAAGAGCCAGAATAAACTTG-3’ (anti-sense). 
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Cell culture and synchronisation procedures 
U2OS cells free from mycoplasma were purchased from American Type Culture Collection (ATCC, HTB-96) 
and were grown in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich) supplemented with 10% fetal 
bovine serum (Life Technologies, Thermo Fisher Scientific), 1% L-glutamine (Life Technologies, Thermo Fisher 
Scientific) and 1% penicillin–streptomycin (Life Technologies, Thermo Fisher Scientific). The generation of GFP-
AURKA, GFP-AURKA-mCherry and GFP-AURKA Lys 162Met-mCherry stable cell lines was previously 
described 16. GFP-AURKA-GFP and GFP-AURKA Lys162Met-GFP stable clones cells were generated by 
transfecting U2OS cells with X-tremeGENE HP transfection reagent (Roche), following the manufacturer’s 
indications. Stable clones were selected in DMEM supplemented with 10% fetal bovine serum, 1% L-glutamine, 
1% penicillin–streptomycin and 500 µg/ml Geneticin (Invivogen). Stable and transient transfections were 
performed with X-tremeGENE HP transfection reagent (Roche) or with Lipofectamine 2000 (Life Technologies, 
Thermo Fisher Scientific), according to the manufacturer’s instructions. For live microscopy, cells were incubated 
in phenol red-free Leibovitz’s L-15 medium (Thermo Fisher Scientific), supplemented with 20% fetal bovine 
serum, 1% L-glutamine and 1% penicillin–streptomycin. Mitotic cells were obtained after synchronisation at the 
G2/M transition with 100 ng/ml nocodazole (Sigma-Aldrich) for 16 h. Cells were washed twice with 1X PBS and 
incubated with prewarmed imaging medium for 30 min to reach metaphase before performing fluorescence 
anisotropy, FRET/FLIM or 2c-FCCS analyses. All live microscopy experiments were performed at 37°C in Nunc 
Lab-Tek II Chamber slides (Thermo Fisher Scientific). 
 
Fluorescence polarisation microscopy 
Fluorescence polarisation analyses were performed on a SP8 (Leica) inverted confocal microscope with a 63X 
oil immersion objective (NA 1.4), and using the Leica Acquisition Suite (LAS)-AF software. As the excitation light 
coming out of the laser is naturally polarized, an analyser integrated in the Leica emission filter wheel was placed 
in the emission pathway before the pinhole. The analyser rotates from a parallel to a perpendicular orientation 
to perform a sequential acquisition of the two corresponding polarised images. Images of GFP polarisation were 
acquired using a 488 nm argon laser and emission was selected between 500 and 550 nm. Image analysis was 
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performed using the Fiji (ImageJ) software and fluorescence anisotropy was calculated as in 17, using the 
following equation: r = (Iצ -Iᵚ)/( Iצ + 2Iᵚ), where r is the fluorescence anisotropy, Iצ and Iᵚ are the parallel and 
the perpendicular polarisations and Iצ + 2Iᵚ is the total polarisation-independent emission. 
 
FLIM microscopy 
FLIM analyses were performed in the time domain with a time-gated custom-built setup as described in 16 and 
driven by the Inscoper hardware (Inscoper). Briefly, cells were excited at 440+/-10 nm and at 480+/-10 nm using 
a white light laser and emission was selected using a  band pass filter of 483/35 nm and of 525/50 nm for 
mTurquoise2 and GFP, respectively. Fluorescence lifetime was calculated with five sequential temporal gates 
of 2.2 nsec each. Mean pixel-by-pixel lifetime was calculated using the following equation: ۦτۧ=ΣΔtiڄIi/ΣIi where 
Δti is the delay time of the ith image acquired following a laser pulse, and I is the pixel-by-pixel fluorescence 
intensity in each image. Lifetime measurements and online calculations were performed with the Inscoper 
software (Inscoper). Pixel-by-pixel lifetime was calculated only when fluorescence intensity was above 3000 
grey levels. To calculate DLifetime, the mean lifetime of the cells expressing the donor alone (AURKA-
mTurquoise2) was calculated for each independent experiment. This mean lifetime value was then used to 
normalise data in all the analysed conditions.  
 
Two-colour fluorescence cross-correlation spectroscopy 
2c-FCCS analyses were carried out on a Leica a SP8 (Leica) inverted confocal microscope with a 63X water 
objective with correcting ring (NA 1.2), combined with a PicoQuant time-correlated single photon counting 
(TCSPC) module and a Fluorescence Lifetime Correlation Spectroscopy (FLCS) integration (PicoHarp, 
PicoQuant). For the GFP/mCherry donor-acceptor pair the following laser sources were used: a pulsed one at 
470 nm and a continuous one at 561 nm, while for the mTurquoise2/superYFP pair we used a pulsed laser 
source at 440 nm and a continuous one at 514 nm. Fluorescence emission was collected simultaneously using 
two avalanche photodiode detectors (APD and Tau-SPAD, PicoQuant). The two emission channels used were, 
500-550 nm and 581-654 nm for GFP/mCherry and 467-499 nm and 525-565 nm for mTurquoise2/superYFP. 
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2c-FCCS measurements were carried out with the Symphotime software (PicoQuant), integratd into the LAS-
AF software (Leica). For each cell, the fluctuation of the fluorescence intensity for both donor-acceptor pairs 
(green/red or cyan/yellow) in the confocal volume was analysed by monitoring three independent points in the 
cytosol. These points were analysed sequentially and in non-photobleaching conditions for 30 sec each. Auto-
correlation and cross-correlation curves were reconstructed from the fluorescence decay with the Symphotime 
software and the lifetime integration as previously reported 21,22, with the Symphotime software. Data were fit 
using the 3D diffusion model, with one diffusing species 21,22. The ratio between cross-correlation and green (for 
GFP/mCherry) or cyan (for mTurquoise2/superYFP) auto-correlation was used to estimate FRET efficiency.  
 
Statistical analyses 
One-way ANOVA and the Dunnet’s method were used to compare the effects of the transfected AURKA 
plasmids on GFP fluorescence anisotropy (Fig. 1C). One-way ANOVA and the Tukey’s method were used to 
compare the effect of the transfected vectors on fluorescence lifetime (Fig. 2B; Supplementary Fig. 1A). One-
way ANOVA on ranks and the Kruskal-Wallis method were used to compare the effect of the transfected vectors 
on fluorescence lifetime (Fig. 2C, 4B).The Student’s t-test was used to compare the effect of a GFP monomer 
and a tandem dimer on fluorescence anisotropy (Fig. 1B) or to compare the effects of superYFP on the lifetime 
of mTurquoise2 (Supplementary Fig. 1B); the Mann-Whitney test was used to compare the cross-
correlation/auto-correlation ratio between normal and Lys162Met AURKA (Fig. 3 and 4C).  
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RESULTS AND DISCUSSION 
 
Homo-FRET within the AURKA biosensor is undetectable by fluorescence polarisation microscopy. 
We previously generated an AURKA FRET biosensor (GFP-AURKA-mCherry) reporting on the 
autophosphorylation of the protein kinase AURKA on Thr288 16. Biochemical studies reported that this post-
translational modification primes the kinase for activation towards a given substrate 23–25. In the perspective of 
using our FRET biosensor in a multiplex FRET context, we modified the GFP-AURKA-mCherry biosensor to 
create a single-colour FRET sensor to detect homo-FRET. We replaced the mCherry acceptor protein located 
at the carboxy terminus of the original AURKA biosensor with an Enhanced Green Fluorescent Protein 
(mEGFP), thereby creating a GFP-AURKA-GFP biosensor (Fig. 1A). Changes in the conformation of GFP-
AURKA-GFP were analysed by following the fluorescence anisotropy of the biosensor, obtained by fluorescence 
polarization microscopy 17. With this approach, decreased anisotropy would correspond to FRET within the 
biosensor.  
We synchronised U2OS cells at mitosis to benefit from a cell cycle phase in which AURKA is active and highly 
abundant at the mitotic spindle (Nikonova et al., 2013), and where the GFP-AURKA-mCherry biosensor displays 
significant hetero-FRET 16. To establish the maximum decrease in anisotropy detectable with our fluorophore 
pair, we compared a GFP monomer and a tandem dimer. For both constructs, we imaged the parallel and 
perpendicular components of the emitted fluorescence. This was performed by exciting the sample with a 
polarised laser, followed by the detection through an analyser in a confocal microscope setup. Similarly to what 
previously described, the dimer displays a decreased anisotropy (mean anisotropy: 0.22) compared to the GFP 
monomer (mean anisotropy: 0.30) in mitotic cells, thus indicating the homotransfer between the two GFP 
fluorophores harbouring different orientations (Fig. 1B) 17. This is consistent with the fact that the rotation period 
of the GFP fluorophore is slower than fluorescence lifetime 26,27. We then evaluated the anisotropy of GFP-
AURKA, of the biosensor GFP-AURKA-GFP and of the kinase-dead version of the biosensor, GFP-AURKA 
Lys162Met-GFP 16, on the mitotic spindle. As previously described 16, the Lys162Met variant of AURKA induces 
mitotic spindle abnormalities such as monopolar or multipolar spindles. The anisotropy of GFP-AURKA was not 
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different from the one of the GFP monomer, indicating that the presence of the kinase does not perturb the 
anisotropy of GFP per se (Fig. 1C).  
However, we did not detect any significant difference between the anisotropy of GFP-AURKA and of the 
biosensor, both in the activated and in the kinase-dead version (Fig. 1C). Although fluorescence anisotropy was 
recently shown to be a suitable approach for FRET biosensors 10, relative differences in anisotropy between 
active and inactive biosensors are often very low. In the case of the AURKA biosensor, the difference between 
the active and the inactive forms of the biosensor was not significant, with the GFP-AURKA-GFP showing a 
slightly increased anisotropy rather than a decreased one. This could be due to the clustering of the GFP-
AURKA-GFP biosensor at the spindle. Indeed, the high mechanical tension taking place at this compartment at 
mitosis could keep the fluorophores in a stable conformation, altering the rotational motility of GFP. Alternatively, 
GFP rotation could also be perturbed by the presence of selected interactors of AURKA at the spindle, which 
could maintain the biosensor in a fixed conformation. Last, our results could also indicate that the two GFP 
fluorophores are in a parallel conformation, making differences in anisotropy undetectable and preventing the 
use of this approach for multiplex FRET in our biosensor setup. 
 
The dark acceptors ShadowG and ShadowY allow for single-colour FRET/FLIM measurements. 
In the perspective of optimising a multiplex FRET strategy for the AURKA biosensor, we then explored whether 
dark acceptors as ShadowG 18 or ShadowY 19 could be used as efficient alternatives to fluorescence anisotropy 
to this end. These proteins were previously demonstrated to be non-fluorescent variants of the Yellow 
Fluorescent Protein (YFP) preventing spectral bleedthrough of the first acceptor in the second donor channel, 
thereby resulting in a suitable strategy for multiplex FRET design. As shown in the original reports, they also 
behave as good acceptors in FRET/FLIM pairs for mGFP or mClover, respectively. These properties of 
ShadowG and ShadowY allow for multi-colour imaging and FRET/FLIM studies with other fluorescent proteins, 
and we previously took advantage of these properties of ShadowG for the setup of multiplex FRET analyses. In 
particular, ShadowG turned out to be an efficient acceptor for the cyan fluorescent protein mTFP1 as well 9, and 
we used the mTFP1-ShadowG donor-acceptor pair in conjunction with a second one constituted by the Large 
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Stoke Shift fluorescent protein mOrange (LSSmOrange) and mKate2. This combination of fluorophores used in 
FRET biosensors allowed us to record two biochemical activities simultaneously 9,28. 
 In light of these previous data, we first monitored the effect of using ShadowG and ShadowY as dark 
acceptors for the cyan donor protein mTurquoise2. We observed a decrease in the lifetime of the donor of ~500 
psec when ShadowG was present in a tandem construct, and of ~800 psec when ShadowY was used 
(Supplementary Fig. 1), demonstrating that both fluorophores are excellent acceptors for mTurquoise2. We then 
replaced the GFP-mCherry donor-acceptor pair of the original AURKA biosensor with mTurquoise2 and 
ShadowG or ShadowY, thereby creating ShadowG-AURKA-mTurquoise2 or ShadowY-AURKA-mTurquoise2 
(Fig. 2B). We then tested the conformational changes of these two biosensors by FRET/FLIM in U2OS cells 
synchronised at mitosis, by calculating the net difference in the lifetime (DLifetime) between the donor-only 
construct (AURKA-mTurquoise2) and ShadowG-AURKA-mTurquoise2 or ShadowY-AURKA-mTurquoise2 at 
the mitotic spindle. DLifetime was used to standardise the decrease in lifetime due to FRET, as lifetime variation 
is the measured parameter directly dependent on the standard deviation of the experimental setup used (50 
psec with our setup 16). We measured a mean DLifetime of ~150 psec for both biosensors (Fig. 2B-C), which 
was similar to the decrease observed for the original GFP-AURKA-mCherry one 16. With the same approach, 
we also tested the impact of kinase-dead AURKA on FRET efficiencies. DLifetime values for both biosensors 
carrying the Lys162Met mutation were half than their wild-type counterparts, indicating lower FRET efficiencies 
when AURKA is catalytically inactive. However, it must be noted that the difference in lifetime between normal 
and kinase-dead AURKA biosensors with dark acceptors (~50 psec) was less remarkable than what observed 
with the GFP/mCherry AURKA biosensor (~120 psec), where the GFP-AURKA Lys162Met- mCherry lifetime 
was comparable to the one of the donor alone 16. 
Our results show that the replacement of the donor-acceptor pair from GFP-mCherry to mTurquoise2-ShadowG 
or ShadowY maintains FRET efficiency. In addition, both dark biosensors show a lowered FRET efficiency when 
the kinase is catalytically dead, although this difference is less pronounced than in the original GFP-AURKA-
mCherry biosensor. It should also be noted that the performance of a FRET biosensor cannot be predicted from 
 11 
tandem constructs. In spite of the significantly better performance of the ShadowY-mTurquoise2 tandem 
compared to the ShadowG-mTurquoise2 one (Supplementary Fig. 1), the corresponding AURKA biosensors 
show an identical response (Fig. 2B and C). Therefore, two additional parameters should be kept into 
consideration. First, the nature of the protein probed within the biosensor and second, the possibility that the 
conformational changes of this protein fall within the Förster’s radius of the donor-acceptor pair or not.   
However, the use of biosensors containing dark acceptors should be considered as a suitable alternative 
to fluorescence anisotropy for the design of multiplex FRET experiments with the AURKA kinase biosensor. In 
this light, cumulating a biosensor of AURKA containing a dark acceptor with a substrate-based biosensor of the 
kinase flanked by the LSSmOrange/mKate2 donor-acceptor pair could allow the simultaneous monitoring of 
AURKA activation by auto-phosophorylation on Thr288 and its activity towards a substrate, on the same cell 
and with a spatiotemporal resolution. 
 
The GFP-AURKA-mCherry biosensor is not suitable to estimate FRET by two-colour FCCS. 
It is known that AURKA is a multifunctional kinase with several subcellular locations, with both mitotic and non-
mitotic functions. While mitotic AURKA is highly abundant in cells 11, the low abundance of non-mitotic pools of 
AURKA often represent a limitation in exploring their function. Our current approach based on FRET/FLIM allows 
to analyse the activation of the kinase only where it is particularly abundant (i.e. the centrosome, the mitotic 
spindle or mitochondria) 16,14, possibly excluding from the analysis other cytosolic pools of AURKA too scarce to 
be analysed with this microscopy technique. Therefore, we turned to two-colour Fluorescence Cross-Correlation 
Spectroscopy (2c-FCCS) to estimate FRET in regions of the cytoplasm where the abundance of AURKA is low 
and the number of photons is insufficient to estimate the activation of AURKA by fluorescence lifetime. 
In 2c-FCCS, the fluctuating signal intensities of the red and the green channels in and out of a confocal 
volume are monitored in real time, and their auto-correlation function is computed together with a cross-
correlation function between the two channels. Besides these measurements, we used the temporal correlation 
of each fluorophore excited by different lasers (pulsed or continuous) to remove the spectral bleed-through of 
GFP into the mCherry channel. This was done following a previously published strategy 21,22 based on 
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Fluorescence Lifetime Correlation Spectroscopy (FLCS) 29. We excited GFP with a pulsed laser and mCherry 
with a continuous laser. We then gave a specific weight to each photon in the green and in the red channel using 
pulsed or continuous calculated lifetime filters. In order to eliminate cross-talk effects between GFP and 
mCherry, these weights were used to build the auto-correlation curves for each fluorophore, and the cross-
correlation curve. Applying this strategy to two separate molecules of GFP and mCherry gives a null cross-
correlation, thereby eliminating potential artefacts in 2c-FCCS experiments due to spectral bleed-through 21,22. 
In 2c-FCCS, the presence of FRET is indicated by a simultaneous decrease of the amplitude of the cross-
correlation curve and the increased amplitude of the green auto-correlation curve 30,31. This allows to use 2c-
FCCS to estimate FRET in co-diffusing molecules, as it is the case for FRET biosensors. 
With this approach, we estimated the green and red auto-correlation curves of the original AURKA 
biosensor (GFP-AURKA-mCherry) and of the kinase-dead GFP-AURKA Lys 162Met-mCherry variant in cells 
synchronised at mitosis. For each cell analysed, we measured three randomly-chosen points in the cytosol to 
estimate FRET efficiency in this compartment. We did not detect any significant difference between active and 
kinase-dead AURKA when we compared the ratio of the amplitudes of the red or green auto-correlation curves 
with the amplitude of the cross-correlation curve (Fig. 3). This was in apparent contradiction with previous data 
acquired in cells where the cytosol was strong enough to perform FRET/FLIM analyses 16, and where we 
detected FRET with the GFP-AURKA-mCherry biosensor. Therefore, we concluded that the ratio between the 
cross-correlation and the green auto-correlation is not sufficiently robust to detect changes due to FRET in the 
original AURKA biosensor. 
As FRET cannot be estimated by 2c-FCCS using the original AURKA biosensor, it is possible that 
mCherry represents a limiting factor for the measurement of FRET via 2c-FCCS, due to its longer dark state 
compared to the one of EGFP-like proteins 32, and its lower brightness (15.84 for mCherry vs 33.6 for mEGFP; 
www.fpbase.org). Changes in the donor-acceptor fluorescent pair should then be envisaged to adapt the AURKA 
biosensor to 2c-FCCS, choosing an acceptor with a higher brightness to ameliorate the robustness of the 
amplitude of the different correlation curves. 
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Replacing the donor-acceptor pair is mandatory to adapt the AURKA biosensor to two-colour FCCS 
To find a suitable donor-acceptor pair to adapt the AURKA biosensor to 2c-FCCS, we first searched for 
a bright acceptor. We decided to replace the usual acceptors of cyan fluorescent proteins Citrine/Venus 
(brightness of approximately 69; www.fpbase.org), by superYFP, a novel dimeric yellow fluorescent protein with 
high brightness based on dLanYFP (the dLanYFP brightness is 112.5; www.fpbase.org). superYFP is a dimer 
of dLanYFP, with a 12-aminoacids linker between the first and the second monomer of dLanYFP replacing the 
last seven amino acids of the first monomer and the first four aminoacids of the second one (Supplementary 
Fig. 2A). The full characterisation of the physicochemical properties of superYFP will be described elsewhere.  
We coupled superYFP to mTurquoise2, as this appeared to be an efficient donor fluorophore in the dark versions 
of the AURKA biosensor (Fig. 2). We then tested the capacity of mTurquoise2 to act as a donor of energy for 
superYFP in a tandem construct. mTurquoise2 displayed a DLifetime of ~600 psec when superYFP was present 
in U2OS cells synchronised at mitosis (Supplementary Fig. 2B), indicating that this donor-acceptor couple is 
suitable for FRET/FLIM analyses.  
In light of these data, we then engineered the superYFP-AURKA-mTurquoise2 biosensor (Fig. 4A). To 
validate this new biosensor, we evaluated its conformational changes at the mitotic spindle by FRET/FLIM. 
Again, we compared the DLifetime between the donor-only construct AURKA-mTurquoise2 and superYFP-
AURKA-mTurquoise2, and we observed a mean DLifetime of ~210 psec in the presence of the acceptor 
(Fig.4B). Unlike the GFP-AURKA-mCherry original biosensor, the presence of the AURKA Lys162Met mutation 
did not abolish FRET efficiency, as observed for the variants of the AURKA biosensor containing dark acceptors. 
The differences in Förster’s radius (R0) for the mTurquoise/superYFP pair (59 Å) compared to GFP/mCherry 
(51 Å; 33) could explain the behaviour of the two biosensors. Applying the FRET equation with the usual value 
k2=2/3, the estimated distance between donor and acceptor is of 83 Å for the normal, active AURKA, and more 
than 97 Å for the kinase-dead. Using the same distances for the superYFP-AURKA-mTurquoise2 active and 
dead biosensors, we calculated lifetime values (2.97 ns for the active form; 3.18 ns for the kinase-dead) 
compatible with what we measured experimentally (3.15 ns for the active; 3.25 ns for the kinase-dead), taking 
3.35 ns as lifetime of the donor alone. It should be noted that the time-gated detection of our system does not 
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yield an unequivocal absolute lifetime value for mTurquoise2 (Theoretical lifetime of mTurquoise2: 4 ns 34; 
lifetime measured with our system: 3.35 ns). This comes from the fact that we do not adjust the decay with 
exponential models, but we directly calculate the temporal mean of the decay function. This temporal mean and 
the lifetime are equal when the function exhibits a mono-exponential decay, and for an infinite integral 
calculation. This is the case for GFP, showing a lifetime of 2.5 ns when measured with an 11 ns-time window. 
However, in the case of mTurquoise2 - which has a lifetime of around 4 ns - the calculation corresponds to a 
finite integral when measured with an 11 ns-time window. We previously reported that the expression of finite 
integrals for the mean lifetime can be corrected, although this is a time-consuming procedure incompatible with 
real-time imaging 35. We provided evidence that this correction is dispensable for FRET, as the differences 
between donor-only and biosensors using non-corrected mean lifetime calculations are maintained whatever 
the choice of fluorescent protein pairs 9. Since this allows for real-time imaging, we here choose to use the direct 
calculation of the mean lifetime even if the absolute value of mTurqoise2 is not reached. Taken together, the 
difference between active and kinase-dead form is the main parameter to be taken into account to estimate the 
quality of any AURKA biosensor. In this light, the difference in the mTurquoise/superYFP biosensors is of 100 
psec, whereas the one observed using the GFP/mCherry biosensors is of 130 psec 16. This indicates that when 
FRET is calculated by FLIM, this new biosensor does not show a better performance. 
However, we used this version of the AURKA biosensor for 2c-FCCS, potentially benefiting from the greater 
brightness of superYFP in the computing of the cross-correlation curve. We calculated the cyan and yellow auto-
correlation curves of superYFP-AURKA-mTurquoise2 and of superYFP-AURKA Lys162Met-mTurquoise2 in 
U2OS cells synchronised at mitosis (Fig. 4C). As done previously for the GFP-AURKA-mCherry biosensor, we 
measured 3 independent points per cell, chosen in a random manner in the cytosol. We observed a simultaneous 
increase of the cyan auto-correlation curve and a decrease of the cross-correlation curve in cells expressing the 
superYFP-AURKA-mTurquoise2 biosensor when compared to the kinase-dead one. The ratio between the 
cross-correlation and the cyan auto-correlation was lower in cells expressing the active biosensor than in cells 
expressing the kinase-dead one (Fig. 4C, right panel). We also noticed that the amplitude of the auto-correlation 
curve of superYFP is higher than the one of mTurquoise2. We reasoned that this could be linked to some 
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photophysical properties of superYFP, induced by the laser power used for monitoring its diffusion. These 
photophysical properties could have the same time scale than the diffusion. If so, we could not discriminate 
between the two processes, and the photophysical effect would lead to an increase in the amplitude when using 
a conventional diffusion model. To verify this, we monitored the amplitude of the auto-correlation curve of 
superYFP after modifying the power of the 514 nm laser. Given that the 2c-FCCS measurements were done 
with a laser power of ~ 1% (Fig. 4C), we chose four different laser powers for comparison: 0.5%, 1%, 3% and 
5%. We didn’t observe any significant alteration in the yellow amplitude, which undergoes a 20% increase at 
most when switching the 514 nm laser from 0.5% to 1% and then remains constant between 1%, 3% and 5% 
(Supplementary Fig. 3). The fact that there is no significant change in the amplitude of the yellow auto-correlation 
curve when changing the laser power suggests that a modification of the photophysical behaviour of superYFP 
may not be the responsible of the observed higher amplitude. Another possibility is that the high amplitude of 
the yellow auto-correlation curve in 2c-FCCS analyses reflects a lower concentration of the yellow moiety in 
comparison to the cyan one. This would be indicative of a slower maturation of superYFP compared to 
mTurquoise2, as superYFP derives from dLanYFP. Taken together, the variations in amplitude of the cyan auto-
correlation and of the cross-correlation curves meet the requirements for FRET within the superYFP-AURKA-
mTurquoise2 biosensor. Although correlation analyses were proven to be a useful approach to characterise 
single-molecule FRET 36,37, we here report for the first time the use of 2c-FCCS to monitor FRET within a 
genetically-encoded biosensor. Last, this new version of the AURKA biosensor containing an 
mTurquoise/superYFP donor-acceptor FRET pair is a suitable tool to investigate the activation of discrete pools 
of AURKA with low abundance and with high spatiotemporal resolution. 
 
CONCLUSIONS 
Here we propose several improvements to the original AURKA FRET biosensor, both in terms of changing the 
donor-acceptor FRET pair for multiplex analyses, or in exploring new approaches to estimate FRET efficiency. 
It might be useful to point out that although fluorescence anisotropy was successfully used to follow multiplex 
FRET among PKA, ERK and cAMP 10, this is clearly not a suitable approach for the AURKA biosensor. The 
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results here described indicate that there is no “golden rule” for FRET biosensors, and that the capacity of every 
biosensor to give a satisfactory response with a particular methodology approaches must be carefully evaluated. 
Changing the donor-acceptor FRET pairs was mandatory to cumulate the analysis of the conformational 
changes of AURKA and of its enzymatic activity towards a particular substrate. Given the fact that AURKA is a 
multifunctional kinase involved in several biochemical pathways 11, designing a strategy for multiplex FRET is a 
first, mandatory step to start understanding how AURKA auto-activates and interacts with its wide range of 
substrates. The spatiotemporal resolution AURKA activation and its concomitant interaction with a substrate, or 
more at a time, is a crucial aspect in the future development of therapeutic strategies in epithelial cancers 
showing an overexpression of AURKA. 
Changes in the way FRET efficiency is calculated, together with improvements in the donor-acceptor 
FRET pair, were also required to evaluate the activation of AURKA when its abundance is low. 2c-FCCS with 
the mTurquoise/superYFP pair efficiently responds to this need, allowing to monitor the activation of AURKA in 
the cytosol. We previously described that AURKA is activated at mitochondria 14, a compartment where the 
kinase is abundant enough to perform FRET/FLIM analyses. The mTurquoise/superYFP AURKA FRET 
biosensor used in conjunction with fluorescent markers for other subcellular compartments could potentially 
shed light in the activation of AURKA at other locations, where the kinase is less abundant. Such activation 
could lead to the identification of novel roles of AURKA, together with novel substrates.  
  
 17 
FIGURE LEGENDS 
 
Fig. 1. The GFP-AURKA-GFP biosensor does not allow the detection of homo-FRET. A. Model illustrating 
the mode of action of the GFP-AURKA-GFP biosensor. This biosensor switches from an open-to-close 
conformation upon autophosphorylation of AURKA on Thr288. While no depolarisation is observed in the open 
conformation, the closed conformation of the biosensor induces a partial depolarisation of the acceptor, due to 
the FRET phenomenon. Of note, the real three-dimensional orientation of the two GFPs is unknown. B. 
Representative parallel and perpendicular polarised images, and corresponding anisotropy quantification of 
U2OS cells synchronised at mitosis and expressing a GFP monomer (upper panels) or a GFP tandem dimer 
(lower panels). C. Representative parallel and perpendicular polarised images, and corresponding anisotropy 
quantification of U2OS cells synchronised at mitosis and expressing GFP-AURKA, GFP-AURKA-GFP or GFP-
AURKA Lys162Met-GFP localised at the mitotic spindle. The pseudocolor scale in B. and C. represents pixel-
by-pixel anisotropy. Transfection conditions are indicated in italics. Anisotropy values for individual cells are 
represented as circles in B., and as squares in C. Data represent means ± s.d. of one representative experiment 
of three. n=30 cells per condition. Scale bar: 10 nm. ***P<0.001 against the ‘GFP’ condition; NS: not significant.  
 
Fig. 2. ShadowG and ShadowY are efficient dark acceptors for mTurquoise2 in the AURKA biosensor. 
A. Model illustrating the mode of action of the ShadowG-AURKA-mTurquoise2 or the ShadowY-AURKA-
mTurquoise2 biosensors. These biosensors switch from an open-to-close conformation upon 
autophosphorylation of AURKA on Thr288, bringing the donor and the acceptor in vicinity and allowing FRET 
detection. B. and C. (Upper panels) Representative fluorescence (mTurquoise2 channel) and DLifetime (donor 
only-biosensor) images of U2OS cells expressing the indicated constructs and synchronised at mitosis. (Lower 
panel) Corresponding DLifetime quantification at the mitotic spindle.  ShG: ShadowG; ShY: ShadowY; mTurq2: 
mTurquoise2. DLifetime values for individual cells are represented as black dots in each boxplot. The bar in 
boxplots represents the median; whiskers extend from the 10th to the 90th percentiles. n=10 cells per condition 
of one representative experiment (of three). Scale bar: 10 nm. ***P<0.001 against the ‘AURKA-mTurquoise2’ 
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condition; aP<0.001 compared to the ‘ShadowG-AURKA-mTurquoise2’ condition in B. or aP<0.05 compared to 
the ‘ShadowY-AURKA-mTurquoise2’ condition in C. 
 
Fig. 3. The GFP-AURKA-mCherry biosensor does not perform FRET by 2c-FFCS. Green and red auto-
correlation curves, together with the respective cross-correlation curves issued from one representative U2OS 
cell expressing GFP-AURKA-mCherry (left panel) or GFP-AURKA Lys162Met-mCherry (middle panel) and 
synchronised at mitosis. Measurements were taken in the cytosol; one independent point per condition is shown. 
Experimental values obtained for each curve are represented as dots. Time is expressed in msec. (Right panel) 
Ratio of the cross-correlation/green auto-correlation values for GFP-AURKA-mCherry (black bar) and GFP-
AURKA Lys162Met-mCherry (white bar). Each n represents the average of three independent points per cell at 
0.01 msec; n=10 cells per condition of one representative experiment (of three). NS: not significant. 
 
Fig. 4. superYFP coupled to mTurquoise2 ameliorates FRET/FLIM detection and allows FRET detection 
by 2c-FCCS. A. Model illustrating the mode of action of the superYFP-AURKA-mTurquoise2 biosensor. It 
switches from an open-to-close conformation upon autophosphorylation of AURKA on Thr288, and allowing 
FRET measurements. Of note, superYFP is a dimeric acceptor. B. Representative fluorescence (mTurquoise2 
channel) and DLifetime (donor only-biosensor) images of U2OS cells expressing the indicated constructs and 
synchronised at mitosis, together with the corresponding DLifetime quantification at the mitotic spindle. sYFP: 
superYFP; mTurq2: mTurquoise2. DLifetime values for individual cells are represented as black dots in each 
boxplot. The bar in boxplots represents the median; whiskers extend from the 10th to the 90th percentiles. n=10 
cells per condition of one representative experiment (of three). Scale bar: 10 µm. C. Cyan and yellow auto-
correlation curves, together with the respective cross-correlation curves issued from one representative U2OS 
cell expressing superYFP-AURKA-mTurquoise2 (left panel) or superYFP-AURKA Lys162Met-mTurquoise2 
(middle panel) and synchronised at mitosis. Measurements were taken in the cytosol; one independent point 
per condition is shown. Experimental values obtained for each curve are represented as dots. Time is expressed 
in msec. (Right panel) Ratio of the cross-correlation/cyan auto-correlation values for superYFP-AURKA-
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mTurquoise2 (black bar) and superYFP-AURKA Lys162Met-mTurquoise2 (white bar). Each n represents the 
average of three independent points per cell at 0.01 msec; n=10 cells per condition of one representative 
experiment (of three) ***P<0.001 against the ‘AURKA-mTurquoise2’ condition (B.), **P<0.01 against the 
‘AURKA’ condition (C.); aP<0.001 compared to the ‘superYFP-AURKA-mTurquoise2’ condition (B.) 
 
SUPPORTING INFORMATION 
Supporting information available: the following files are available free of charge 
- Supplementary Figure 1: efficiency of the mTurquoise-ShadowG or ShadowY donor/acceptor FRET pairs. 
- Supplementary Figure 2: amino acidic sequence of superYFP, and efficiency of the mTurquoise-superYFP 
donor-acceptor FRET pair. 
- Supplementary Figure 3: superYFP G(0) values at different 514 nm laser powers. 
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